Tag: Prescription Drugs
Medicare Spending on Essential Medicines Up 116 Percent From 2011 to 2015
22 percent of increased total spending due to higher per-unit cost of existing drugs
Common Therapy for Obstetric Cholestasis Found Ineffective
Treatment with ursodeoxycholic acid versus placebo yielded no significant difference in outcome
Addition of Sotagliflozin for T1DM Alters Renal Hemodynamics
Addition of SOTA tied to reductions in estimated glomerular filtration rate, blood pressure
2012 to 2018 Saw Substantial Rise in Naloxone Dispensing
Regional variation in naloxone dispensing considerable; rates lowest in most rural counties
Study Explores Dose Ranges for Efpeglenatide in Early T2DM
Safety profile consistent with other long-acting glucagon-like peptide 1 receptor agonists
Brand-Brand Competition Has Not Cut Prices in Pharma Market
Review shows evidence that brand-brand competition was mediated by quality of competing drugs
Compliance With Meds Falters With Age in Youth Born With HIV
Prevalence of nonadherence increased from preadolescence to late adolescence/young adulthood
Ibrutinib-Rituximab Beats Chemoimmunotherapy for CLL
Progression-free, overall survival improved in the ibrutinib-rituximab group at three years
Trump Admin Announces Plan to Allow Drug Imports From Canada
Plan will start by exploring options for importing certain prescription drugs to lower costs for Americans
Oral Semaglutide Reduces HbA1c, Weight in Patients With T2DM
Semaglutide has a safety and tolerability profile consistent with other GLP-1 receptor agonists
